{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:08:55Z","timestamp":1792782535916,"version":"4.5.0"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Inserm International Research Project, France"},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["TauPMN"],"award-info":[{"award-number":["TauPMN"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Health Research Institutes, Taiwan","award":["NHRI-EX114-11431NI"],"award-info":[{"award-number":["NHRI-EX114-11431NI"]}],"id":[{"id":"https:\/\/ror.org\/02r6fpx29","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Science and Technology Council, Taiwan","award":["NSTC 113-2923-E-038-014"],"award-info":[{"award-number":["NSTC 113-2923-E-038-014"]}],"id":[{"id":"https:\/\/ror.org\/02kv4zf79","id-type":"ROR","asserted-by":"crossref"}]},{"name":"WILL Chair France 2023"},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 114 -2927-I-038 -504\/INSERM"],"award-info":[{"award-number":["NSTC 114 -2927-I-038 -504\/INSERM"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["SPF20160936343"],"award-info":[{"award-number":["SPF20160936343"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["NSTC 114 -2927-I-038 -504\/INSERM"],"award-info":[{"award-number":["NSTC 114 -2927-I-038 -504\/INSERM"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondation de France, France","award":["TauPMN"],"award-info":[{"award-number":["TauPMN"]}],"id":[{"id":"https:\/\/ror.org\/02zkxjz73","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100018694","name":"HORIZON EUROPE Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["101208351"],"award-info":[{"award-number":["101208351"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00044-026-03583-w","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:27:52Z","timestamp":1791181672000},"page":"2007-2027","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From danger to resolution: targeting purinergic signaling in CNS diseases"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0403-5311","authenticated-orcid":false,"given":"Camille","family":"Degryse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7038-4949","authenticated-orcid":false,"given":"Kirti","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6261-4230","authenticated-orcid":false,"given":"Luc","family":"Bu\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0507-9243","authenticated-orcid":false,"given":"Thierry","family":"Burnouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5691-431X","authenticated-orcid":false,"given":"David","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6996-5332","authenticated-orcid":false,"given":"Ming-Li","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"3583_CR1","doi-asserted-by":"publisher","first-page":"102693","DOI":"10.1016\/j.pneurobio.2024.102693","volume":"243","author":"S Carracedo","year":"2024","unstructured":"Carracedo S, Launay A, Dechelle-Marquet PA, Faivre E, Blum D, Delarasse C, et al. Purinergic-associated immune responses in neurodegenerative diseases. Prog Neurobiol. 2024;243:102693. https:\/\/doi.org\/10.1016\/j.pneurobio.2024.102693.","journal-title":"Prog Neurobiol"},{"issue":"9","key":"3583_CR2","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/s41590-021-00994-2","volume":"22","author":"T Croese","year":"2021","unstructured":"Croese T, Castellani G, Schwartz M. Immune cell compartmentalization for brain surveillance and protection. Nat Immunol. 2021;22(9):1083\u201392. https:\/\/doi.org\/10.1038\/s41590-021-00994-2.","journal-title":"Nat Immunol"},{"issue":"12","key":"3583_CR3","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1016\/j.immuni.2025.11.010","volume":"58","author":"MW Kim","year":"2025","unstructured":"Kim MW, Kipnis J. Glymphatics and meningeal lymphatics unlock the brain-immune code. Immunity. 2025;58(12):3153. https:\/\/doi.org\/10.1016\/j.immuni.2025.11.010.","journal-title":"Immunity"},{"key":"3583_CR4","doi-asserted-by":"publisher","unstructured":"Cugurra A, Mamuladze T, Rustenhoven J, Dykstra T, Beroshvili G, Greenberg ZJ, et al. Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma. Science. 2021;373(6553). https:\/\/doi.org\/10.1126\/science.abf7844.","DOI":"10.1126\/science.abf7844"},{"issue":"10","key":"3583_CR5","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/00004647-200110000-00001","volume":"21","author":"D Attwell","year":"2001","unstructured":"Attwell D, Laughlin SB. An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab. 2001;21(10):1133\u201345. https:\/\/doi.org\/10.1097\/00004647-200110000-00001.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"3583_CR6","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/s41598-025-30717-8","volume":"16","author":"H Cheng","year":"2026","unstructured":"Cheng H, Gao Y, Shang H, Han W, Zhang X, Gao R, et al. Selective antagonism of adenosine A2A receptor reduces hypobaric hypoxia-induced neuroinflammation by inhibiting cGAS-STING pathway. Sci Rep. 2026;16(1):1091. https:\/\/doi.org\/10.1038\/s41598-025-30717-8.","journal-title":"Sci Rep"},{"key":"3583_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.brainresbull.2018.10.014","volume":"151","author":"L Erb","year":"2019","unstructured":"Erb L, Woods LT, Khalafalla MG, Weisman GA. Purinergic signaling in Alzheimer\u2019s disease. Brain Res Bull. 2019;151:25\u201337. https:\/\/doi.org\/10.1016\/j.brainresbull.2018.10.014.","journal-title":"Brain Res Bull"},{"issue":"3","key":"3583_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11302-013-9357-4","volume":"9","author":"F Jacob","year":"2013","unstructured":"Jacob F, P\u00e9rez Novo C, Bachert C, Van Crombruggen K. Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses. Purinergic Signal. 2013;9(3):285\u2013306. https:\/\/doi.org\/10.1007\/s11302-013-9357-4.","journal-title":"Purinergic Signal"},{"issue":"6","key":"3583_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","volume":"140","author":"C Nathan","year":"2010","unstructured":"Nathan C, Ding A, Nonresolving Inflammation. Cell. 2010;140(6):871\u201382. https:\/\/doi.org\/10.1016\/j.cell.2010.02.029.","journal-title":"Cell"},{"issue":"9","key":"3583_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.tips.2007.07.002","volume":"28","author":"F Di Virgilio","year":"2007","unstructured":"Di Virgilio F. Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol Sci. 2007;28(9):465\u201372. https:\/\/doi.org\/10.1016\/j.tips.2007.07.002.","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"3583_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","volume":"19","author":"L Antonioli","year":"2013","unstructured":"Antonioli L, Pacher P, Vizi ES, Hask\u00f3 G. CD39 and CD73 in immunity and inflammation. Trends Mol Med. 2013;19(6):355\u201367. https:\/\/doi.org\/10.1016\/j.molmed.2013.03.005.","journal-title":"Trends Mol Med"},{"issue":"1","key":"3583_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/imr.12528","volume":"276","author":"B Allard","year":"2017","unstructured":"Allard B, Longhi MS, Robson SC, Stagg J. The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets. Immunol Rev. 2017;276(1):121\u201344. https:\/\/doi.org\/10.1111\/imr.12528.","journal-title":"Immunol Rev"},{"issue":"1","key":"3583_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-023-01733-x","volume":"22","author":"C Xia","year":"2023","unstructured":"Xia C, Yin S, To KKW, Fu L. CD39\/CD73\/A2AR pathway and cancer immunotherapy. Mol Cancer. 2023;22(1):44. https:\/\/doi.org\/10.1186\/s12943-023-01733-x.","journal-title":"Mol Cancer"},{"issue":"6508","key":"3583_CR14","doi-asserted-by":"publisher","first-page":"eabb0556","DOI":"10.1126\/science.abb0556","volume":"369","author":"W Peng","year":"2020","unstructured":"Peng W, Wu Z, Song K, Zhang S, Li Y, Xu M. Regulation of sleep homeostasis mediator adenosine by basal forebrain glutamatergic neurons. Science. 2020;369(6508):eabb0556. https:\/\/doi.org\/10.1126\/science.abb0556.","journal-title":"Science"},{"issue":"4","key":"3583_CR15","doi-asserted-by":"publisher","first-page":"748","DOI":"10.20517\/cdr.2023.63","volume":"6","author":"AR Victoria","year":"2023","unstructured":"Victoria AR, Joel L, Todd WB, Julien D. Unlocking antitumor immunity with adenosine receptor blockers. Cancer Drug Resist. 2023;6(4):748\u201367. https:\/\/doi.org\/10.20517\/cdr.2023.63.","journal-title":"Cancer Drug Resist"},{"issue":"1","key":"3583_CR16","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41467-017-00551-2","volume":"8","author":"Z Liu","year":"2017","unstructured":"Liu Z, Yan S, Wang J, Xu Y, Wang Y, Zhang S, et al. Endothelial adenosine A2a receptor-mediated glycolysis is essential for pathological retinal angiogenesis. Nat Commun. 2017;8(1):584. https:\/\/doi.org\/10.1038\/s41467-017-00551-2.","journal-title":"Nat Commun"},{"issue":"9","key":"3583_CR17","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd2638","volume":"7","author":"G Hask\u00f3","year":"2008","unstructured":"Hask\u00f3 G, Linden J, Cronstein B, Pacher P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discovery. 2008;7(9):759\u201370. https:\/\/doi.org\/10.1038\/nrd2638.","journal-title":"Nat Rev Drug Discovery"},{"issue":"12","key":"3583_CR18","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/nrc3613","volume":"13","author":"L Antonioli","year":"2013","unstructured":"Antonioli L, Blandizzi C, Pacher P, Hask\u00f3 G. Immunity, inflammation and cancer: a leading role for adenosine. Nat Rev Cancer. 2013;13(12):842\u201357. https:\/\/doi.org\/10.1038\/nrc3613.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3583_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nrendo.2015.10","volume":"11","author":"L Antonioli","year":"2015","unstructured":"Antonioli L, Blandizzi C, Cs\u00f3ka B, Pacher P, Hask\u00f3 G. Adenosine signalling in diabetes mellitus\u2014pathophysiology and therapeutic considerations. Nat Reviews Endocrinol. 2015;11(4):228\u201341. https:\/\/doi.org\/10.1038\/nrendo.2015.10.","journal-title":"Nat Reviews Endocrinol"},{"issue":"4","key":"3583_CR20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S1471-4892(02)00172-8","volume":"2","author":"G Hask\u00f3","year":"2002","unstructured":"Hask\u00f3 G, Deitch EA, Szab\u00f3 C, N\u00e9meth ZH, Vizi ES. Adenosine: a potential mediator of immunosuppression in multiple organ failure. Curr Opin Pharmacol. 2002;2(4):440\u20134. https:\/\/doi.org\/10.1016\/S1471-4892(02)00172-8.","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"3583_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0165-6147(02)00045-7","volume":"24","author":"MR Blackburn","year":"2003","unstructured":"Blackburn MR. Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice. Trends Pharmacol Sci. 2003;24(2):66\u201370. https:\/\/doi.org\/10.1016\/S0165-6147(02)00045-7.","journal-title":"Trends Pharmacol Sci"},{"key":"3583_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.niox.2017.11.001","volume":"72","author":"MG Costales","year":"2018","unstructured":"Costales MG, Alam MS, Cavanaugh C, Williams KM. Extracellular adenosine produced by ecto-5\u2019-nucleotidase (CD73) regulates macrophage pro-inflammatory responses, nitric oxide production, and favors Salmonella persistence. Nitric Oxide. 2018;72:7\u201315. https:\/\/doi.org\/10.1016\/j.niox.2017.11.001.","journal-title":"Nitric Oxide"},{"issue":"12","key":"3583_CR23","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrc.2017.86","volume":"17","author":"D Vijayan","year":"2017","unstructured":"Vijayan D, Young A, Teng MWL, Smyth MJ. Targeting immunosuppressive adenosine in cancer. Nat Rev Cancer. 2017;17(12):709\u201324. https:\/\/doi.org\/10.1038\/nrc.2017.86.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3583_CR24","doi-asserted-by":"publisher","first-page":"5911","DOI":"10.1038\/s41467-021-26134-w","volume":"12","author":"E Schneider","year":"2021","unstructured":"Schneider E, Winzer R, Rissiek A, Ricklefs I, Meyer-Schwesinger C, Ricklefs FL, et al. CD73-mediated adenosine production by CD8 T cell-derived extracellular vesicles constitutes an intrinsic mechanism of immune suppression. Nat Commun. 2021;12(1):5911. https:\/\/doi.org\/10.1038\/s41467-021-26134-w.","journal-title":"Nat Commun"},{"issue":"35","key":"3583_CR25","doi-asserted-by":"publisher","first-page":"13132","DOI":"10.1073\/pnas.0605251103","volume":"103","author":"A Ohta","year":"2006","unstructured":"Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MK, et al. A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci U S A. 2006;103(35):13132\u20137. https:\/\/doi.org\/10.1073\/pnas.0605251103.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3583_CR26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1182\/blood-2007-03-081646","volume":"111","author":"PE Zarek","year":"2008","unstructured":"Zarek PE, Huang CT, Lutz ER, Kowalski J, Horton MR, Linden J, et al. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood. 2008;111(1):251\u20139. https:\/\/doi.org\/10.1182\/blood-2007-03-081646.","journal-title":"Blood"},{"issue":"8","key":"3583_CR27","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1158\/2159-8290.Cd-14-0341","volume":"4","author":"A Young","year":"2014","unstructured":"Young A, Mittal D, Stagg J, Smyth MJ. Targeting cancer-derived adenosine: new therapeutic approaches. Cancer Discov. 2014;4(8):879\u201388. https:\/\/doi.org\/10.1158\/2159-8290.Cd-14-0341.","journal-title":"Cancer Discov"},{"issue":"3","key":"3583_CR28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1161\/atvbaha.115.306885","volume":"36","author":"T Gremmel","year":"2016","unstructured":"Gremmel T, Yanachkov IB, Yanachkova MI, Wright GE, Wider J, Undyala VV, et al. Synergistic Inhibition of Both P2Y1 and P2Y12 Adenosine Diphosphate Receptors As Novel Approach to Rapidly Attenuate Platelet-Mediated Thrombosis. Arterioscler Thromb Vasc Biol. 2016;36(3):501\u20139. https:\/\/doi.org\/10.1161\/atvbaha.115.306885.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"3583_CR29","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1053\/j.jvca.2013.01.008","volume":"27","author":"PA Patel","year":"2013","unstructured":"Patel PA, Lane B, Augoustides JG. Progress in platelet blockers: the target is the P2Y12 receptor. J Cardiothorac Vasc Anesth. 2013;27(3):620\u20134. https:\/\/doi.org\/10.1053\/j.jvca.2013.01.008.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"2","key":"3583_CR30","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1161\/atvbaha.110.219501","volume":"31","author":"D Iy\u00fa","year":"2011","unstructured":"Iy\u00fa D, Glenn JR, White AE, Fox SC, Heptinstall S. Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonist. Arterioscler Thromb Vasc Biol. 2011;31(2):416\u201322. https:\/\/doi.org\/10.1161\/atvbaha.110.219501.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6643","key":"3583_CR31","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/41771","volume":"388","author":"C Ledent","year":"1997","unstructured":"Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ, et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature. 1997;388(6643):674\u20138. https:\/\/doi.org\/10.1038\/41771.","journal-title":"Nature"},{"issue":"3","key":"3583_CR32","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1080\/09537104.2017.1306043","volume":"29","author":"E Fuentes","year":"2018","unstructured":"Fuentes E, Fuentes M, Caballero J, Palomo I, Hinz S, El-Tayeb A, et al. Adenosine A(2A) receptor agonists with potent antiplatelet activity. Platelets. 2018;29(3):292\u2013300. https:\/\/doi.org\/10.1080\/09537104.2017.1306043.","journal-title":"Platelets"},{"key":"3583_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.vph.2018.11.005","volume":"113","author":"M Boncler","year":"2019","unstructured":"Boncler M, Wzorek J, Wolska N, Polak D, Watala C, Rozalski M. Adenosine receptor agonists deepen the inhibition of platelet aggregation by P2Y(12) antagonists. Vascul Pharmacol. 2019;113:47\u201356. https:\/\/doi.org\/10.1016\/j.vph.2018.11.005.","journal-title":"Vascul Pharmacol"},{"issue":"3","key":"3583_CR34","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s11332-022-00970-9","volume":"19","author":"MR Bizuti","year":"2023","unstructured":"Bizuti MR, de Camargo Schwede E, Haag FB, Marafon F, da Silva Rosa Bonadiman B, Bagatini MD, et al. Concurrent training is able to increase the activity of adenosine deaminase in platelets in young women. Sport Sci Health. 2023;19(3):849\u201359. https:\/\/doi.org\/10.1007\/s11332-022-00970-9.","journal-title":"Sport Sci Health"},{"issue":"4","key":"3583_CR35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.stemcr.2019.02.009","volume":"12","author":"O Leiter","year":"2019","unstructured":"Leiter O, Seidemann S, Overall RW, Ramasz B, Rund N, Schallenberg S, et al. Exercise-Induced Activated Platelets Increase Adult Hippocampal Precursor Proliferation and Promote Neuronal Differentiation. Stem Cell Rep. 2019;12(4):667\u201379. https:\/\/doi.org\/10.1016\/j.stemcr.2019.02.009.","journal-title":"Stem Cell Rep"},{"key":"3583_CR36","doi-asserted-by":"publisher","unstructured":"Marcinek K, Luzak B, Rozalski M. The Effects of Caffeine on Blood Platelets and the Cardiovascular System through Adenosine Receptors. Int J Mol Sci. 2024;25(16). https:\/\/doi.org\/10.3390\/ijms25168905.","DOI":"10.3390\/ijms25168905"},{"issue":"9","key":"3583_CR37","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/12447","volume":"5","author":"K Enjyoji","year":"1999","unstructured":"Enjyoji K, S\u00e9vigny J, Lin Y, Frenette PS, Christie PD, Esch JSA, et al. Targeted disruption of cd39\/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med. 1999;5(9):1010\u20137. https:\/\/doi.org\/10.1038\/12447.","journal-title":"Nat Med"},{"issue":"9","key":"3583_CR38","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1161\/atvbaha.116.307374","volume":"36","author":"R Covarrubias","year":"2016","unstructured":"Covarrubias R, Chepurko E, Reynolds A, Huttinger ZM, Huttinger R, Stanfill K, et al. Role of the CD39\/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice. Arterioscler Thromb Vasc Biol. 2016;36(9):1809\u201320. https:\/\/doi.org\/10.1161\/atvbaha.116.307374.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"3583_CR39","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1172\/jci10649","volume":"109","author":"DJ Pinsky","year":"2002","unstructured":"Pinsky DJ, Broekman MJ, Peschon JJ, Stocking KL, Fujita T, Ramasamy R, et al. Elucidation of the thromboregulatory role of CD39\/ectoapyrase in the ischemic brain. J Clin Invest. 2002;109(8):1031\u201340. https:\/\/doi.org\/10.1172\/jci10649.","journal-title":"J Clin Invest"},{"issue":"125","key":"3583_CR40","doi-asserted-by":"publisher","first-page":"ra45","DOI":"10.1126\/scisignal.2000549","volume":"3","author":"Y Chen","year":"2010","unstructured":"Chen Y, Yao Y, Sumi Y, Li A, To UK, Elkhal A, et al. Purinergic Signaling: A Fundamental Mechanism in Neutrophil Activation. Sci Signal. 2010;3(125):ra45\u2013ra. https:\/\/doi.org\/10.1126\/scisignal.2000549.","journal-title":"Sci Signal"},{"issue":"5806","key":"3583_CR41","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1126\/science.1132559","volume":"314","author":"Y Chen","year":"2006","unstructured":"Chen Y, Corriden R, Inoue Y, Yip L, Hashiguchi N, Zinkernagel A, et al. ATP Release Guides Neutrophil Chemotaxis via P2Y2 and A3 Receptors. Science. 2006;314(5806):1792\u20135. https:\/\/doi.org\/10.1126\/science.1132559.","journal-title":"Science"},{"issue":"3","key":"3583_CR42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.tcm.2008.01.006","volume":"18","author":"HK Eltzschig","year":"2008","unstructured":"Eltzschig HK, Macmanus CF, Colgan SP. Neutrophils as sources of extracellular nucleotides: functional consequences at the vascular interface. Trends Cardiovasc Med. 2008;18(3):103\u20137. https:\/\/doi.org\/10.1016\/j.tcm.2008.01.006.","journal-title":"Trends Cardiovasc Med"},{"issue":"3","key":"3583_CR43","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11302-021-09786-7","volume":"17","author":"DS Rubenich","year":"2021","unstructured":"Rubenich DS, de Souza PO, Omizzollo N, Lenz GS, Sevigny J, Braganhol E. Neutrophils: fast and furious-the nucleotide pathway. Purinergic Signal. 2021;17(3):371\u201383. https:\/\/doi.org\/10.1007\/s11302-021-09786-7.","journal-title":"Purinergic Signal"},{"issue":"5","key":"3583_CR44","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/bf00916765","volume":"13","author":"SM Kubersky","year":"1989","unstructured":"Kubersky SM, Hirschhorn R, Broekman MJ, Cronstein BN. Occupancy of adenosine receptors on human neutrophils inhibits respiratory burst stimulated by ingestion of complement-coated particles and occupancy of chemoattractant but not Fc receptors. Inflammation. 1989;13(5):591\u20139. https:\/\/doi.org\/10.1007\/bf00916765.","journal-title":"Inflammation"},{"issue":"5","key":"3583_CR45","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1086\/315084","volume":"180","author":"GW Sullivan","year":"1999","unstructured":"Sullivan GW, Linden J, Buster BL, Scheld WM. Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram. J Infect Dis. 1999;180(5):1550\u201360. https:\/\/doi.org\/10.1086\/315084.","journal-title":"J Infect Dis"},{"issue":"1","key":"3583_CR46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/infdis\/jiu050","volume":"210","author":"P Liu","year":"2014","unstructured":"Liu P, Pian Y, Li X, Liu R, Xie W, Zhang C, et al. Streptococcus suis Adenosine Synthase Functions as an Effector in Evasion of PMN-mediated Innate Immunity. J Infect Dis. 2014;210(1):35\u201345. https:\/\/doi.org\/10.1093\/infdis\/jiu050.","journal-title":"J Infect Dis"},{"issue":"3","key":"3583_CR47","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/jlb.4ma0120-115rr","volume":"108","author":"N Siwapornchai","year":"2020","unstructured":"Siwapornchai N, Lee JN, Tchalla EYI, Bhalla M, Yeoh JH, Roggensack SE, et al. Extracellular adenosine enhances the ability of PMNs to kill Streptococcus pneumoniae by inhibiting IL-10 production. J Leukoc Biol. 2020;108(3):867\u201382. https:\/\/doi.org\/10.1002\/jlb.4ma0120-115rr.","journal-title":"J Leukoc Biol"},{"issue":"10","key":"3583_CR48","doi-asserted-by":"publisher","first-page":"e13218","DOI":"10.1111\/acel.13218","volume":"19","author":"M Bhalla","year":"2020","unstructured":"Bhalla M, Simmons SR, Abamonte A, Herring SE, Roggensack SE, Bou Ghanem EN. Extracellular adenosine signaling reverses the age-driven decline in the ability of neutrophils to kill Streptococcus pneumoniae. Aging Cell. 2020;19(10):e13218. https:\/\/doi.org\/10.1111\/acel.13218.","journal-title":"Aging Cell"},{"issue":"1","key":"3583_CR49","doi-asserted-by":"publisher","first-page":"G10","DOI":"10.1152\/ajpgi.00192.2025","volume":"330","author":"B Gromova","year":"2026","unstructured":"Gromova B, Kupcova V, Longhi MS, Gardlik R. Neutrophil-T cell cross talk in noninfectious liver diseases. Am J Physiol Gastrointest Liver Physiol. 2026;330(1):G10\u201328. https:\/\/doi.org\/10.1152\/ajpgi.00192.2025.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"3583_CR50","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/s0306-3623(96)00169-3","volume":"28","author":"BB Fredholm","year":"1997","unstructured":"Fredholm BB. Purines and neutrophil leukocytes. Gen Pharmacol. 1997;28(3):345\u201350. https:\/\/doi.org\/10.1016\/s0306-3623(96)00169-3.","journal-title":"Gen Pharmacol"},{"issue":"1","key":"3583_CR51","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1189\/jlb.0204066","volume":"76","author":"Y Chen","year":"2004","unstructured":"Chen Y, Shukla A, Namiki S, Insel PA, Junger WG. A putative osmoreceptor system that controls neutrophil function through the release of ATP, its conversion to adenosine, and activation of A2 adenosine and P2 receptors. J Leukoc Biol. 2004;76(1):245\u201353. https:\/\/doi.org\/10.1189\/jlb.0204066.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"3583_CR52","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0049-3848(00)00218-8","volume":"98","author":"GJ del Zoppo","year":"2000","unstructured":"del Zoppo GJ, Hallenbeck JM. Advances in the Vascular Pathophysiology of Ischemic Stroke. Thromb Res. 2000;98(3):73\u201381. https:\/\/doi.org\/10.1016\/S0049-3848(00)00218-8.","journal-title":"Thromb Res"},{"issue":"1","key":"3583_CR53","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1006\/exnr.2001.7835","volume":"173","author":"DF Emerich","year":"2002","unstructured":"Emerich DF, Dean RL 3rd, Bartus RT. The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct? Exp Neurol. 2002;173(1):168\u201381. https:\/\/doi.org\/10.1006\/exnr.2001.7835.","journal-title":"Exp Neurol"},{"issue":"1","key":"3583_CR54","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.pbb.2007.04.015","volume":"87","author":"A Durukan","year":"2007","unstructured":"Durukan A, Tatlisumak T. Acute ischemic stroke: Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav. 2007;87(1):179\u201397. https:\/\/doi.org\/10.1016\/j.pbb.2007.04.015.","journal-title":"Pharmacol Biochem Behav"},{"issue":"7","key":"3583_CR55","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1172\/jci124804","volume":"129","author":"V Yadav","year":"2019","unstructured":"Yadav V, Chi L, Zhao R, Tourdot BE, Yalavarthi S, Jacobs BN, et al. Ectonucleotidase tri(di)phosphohydrolase-1 (ENTPD-1) disrupts inflammasome\/interleukin 1\u03b2-driven venous thrombosis. J Clin Invest. 2019;129(7):2872\u20137. https:\/\/doi.org\/10.1172\/jci124804.","journal-title":"J Clin Invest"},{"issue":"1","key":"3583_CR56","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11302-022-09905-y","volume":"19","author":"L Wang","year":"2023","unstructured":"Wang L, Li Y-J, Yang X, Yang B, Zhang X, Zhang J, et al. Purinergic signaling: a potential therapeutic target for ischemic stroke. Purinergic Signalling. 2023;19(1):173\u201383. https:\/\/doi.org\/10.1007\/s11302-022-09905-y.","journal-title":"Purinergic Signalling"},{"issue":"6002","key":"3583_CR57","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1126\/science.1195491","volume":"330","author":"B McDonald","year":"2010","unstructured":"McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CC, et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science. 2010;330(6002):362\u20136. https:\/\/doi.org\/10.1126\/science.1195491.","journal-title":"Science"},{"issue":"2","key":"3583_CR58","doi-asserted-by":"publisher","first-page":"108260","DOI":"10.1016\/j.celrep.2020.108260","volume":"33","author":"M El Amki","year":"2020","unstructured":"El Amki M, Gl\u00fcck C, Binder N, Middleham W, Wyss MT, Weiss T, et al. Neutrophils Obstructing Brain Capillaries Are a Major Cause of No-Reflow in Ischemic Stroke. Cell Rep. 2020;33(2):108260. https:\/\/doi.org\/10.1016\/j.celrep.2020.108260.","journal-title":"Cell Rep"},{"issue":"10","key":"3583_CR59","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1161\/01.str.27.10.1739","volume":"27","author":"SE Akopov","year":"1996","unstructured":"Akopov SE, Simonian NA, Grigorian GS. Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. Stroke. 1996;27(10):1739\u201343. https:\/\/doi.org\/10.1161\/01.str.27.10.1739.","journal-title":"Stroke"},{"issue":"9","key":"3583_CR60","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","volume":"22","author":"U Dirnagl","year":"1999","unstructured":"Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22(9):391\u20137. https:\/\/doi.org\/10.1016\/S0166-2236(99)01401-0.","journal-title":"Trends Neurosci"},{"issue":"6","key":"3583_CR61","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/ana.1010","volume":"49","author":"M Mayne","year":"2001","unstructured":"Mayne M, Fotheringham J, Yan HJ, Power C, Del Bigio MR, Peeling J, et al. Adenosine A2A receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage. Ann Neurol. 2001;49(6):727\u201335. https:\/\/doi.org\/10.1002\/ana.1010.","journal-title":"Ann Neurol"},{"issue":"4","key":"3583_CR62","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1182\/blood-2007-10-117044","volume":"111","author":"T Eckle","year":"2008","unstructured":"Eckle T, Faigle M, Grenz A, Laucher S, Thompson LF, Eltzschig HK. A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood. 2008;111(4):2024\u201335. https:\/\/doi.org\/10.1182\/blood-2007-10-117044.","journal-title":"Blood"},{"issue":"16","key":"3583_CR63","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1182\/blood-2014-04-571679","volume":"124","author":"R Darbousset","year":"2014","unstructured":"Darbousset R, Delierneux C, Mezouar S, Hego A, Lecut C, Guillaumat I, et al. P2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in mice. Blood. 2014;124(16):2575\u201385. https:\/\/doi.org\/10.1182\/blood-2014-04-571679.","journal-title":"Blood"},{"issue":"3","key":"3583_CR64","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.4049\/jimmunol.166.3.1611","volume":"166","author":"A la Sala","year":"2001","unstructured":"la Sala A, Ferrari D, Corinti S, Cavani A, Di Virgilio F, Girolomoni G. Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses. J Immunol. 2001;166(3):1611\u20137. https:\/\/doi.org\/10.4049\/jimmunol.166.3.1611.","journal-title":"J Immunol"},{"issue":"4","key":"3583_CR65","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","volume":"110","author":"G Borsellino","year":"2007","unstructured":"Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, et al. Expression of ectonucleotidase CD39 by Foxp3\u2009+\u2009Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007;110(4):1225\u201332. https:\/\/doi.org\/10.1182\/blood-2006-12-064527.","journal-title":"Blood"},{"issue":"11","key":"3583_CR66","doi-asserted-by":"publisher","first-page":"5713","DOI":"10.4049\/jimmunol.1200545","volume":"188","author":"JH Mills","year":"2012","unstructured":"Mills JH, Kim DG, Krenz A, Chen JF, Bynoe MS. A2A adenosine receptor signaling in lymphocytes and the central nervous system regulates inflammation during experimental autoimmune encephalomyelitis. J Immunol. 2012;188(11):5713\u201322. https:\/\/doi.org\/10.4049\/jimmunol.1200545.","journal-title":"J Immunol"},{"key":"3583_CR67","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12974-016-0512-z","volume":"13","author":"J Ingwersen","year":"2016","unstructured":"Ingwersen J, Wingerath B, Graf J, Lepka K, Hofrichter M, Schr\u00f6ter F, et al. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation. J Neuroinflammation. 2016;13:48. https:\/\/doi.org\/10.1186\/s12974-016-0512-z.","journal-title":"J Neuroinflammation"},{"key":"3583_CR68","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbr.2018.02.038","volume":"347","author":"PZ Chen","year":"2018","unstructured":"Chen PZ, He WJ, Zhu ZR, E GJ, Xu G, Chen DW, et al. Adenosine A(2A) receptor involves in neuroinflammation-mediated cognitive decline through activating microglia under acute hypobaric hypoxia. Behav Brain Res. 2018;347:99\u2013107. https:\/\/doi.org\/10.1016\/j.bbr.2018.02.038.","journal-title":"Behav Brain Res"},{"issue":"6","key":"3583_CR69","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/nn1472","volume":"8","author":"D Davalos","year":"2005","unstructured":"Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci. 2005;8(6):752\u20138. https:\/\/doi.org\/10.1038\/nn1472.","journal-title":"Nat Neurosci"},{"issue":"12","key":"3583_CR70","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/nn1805","volume":"9","author":"SE Haynes","year":"2006","unstructured":"Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, Gan WB, et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci. 2006;9(12):1512\u20139. https:\/\/doi.org\/10.1038\/nn1805.","journal-title":"Nat Neurosci"},{"issue":"7139","key":"3583_CR71","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/nature05704","volume":"446","author":"S Koizumi","year":"2007","unstructured":"Koizumi S, Shigemoto-Mogami Y, Nasu-Tada K, Shinozaki Y, Ohsawa K, Tsuda M, et al. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature. 2007;446(7139):1091\u20135. https:\/\/doi.org\/10.1038\/nature05704.","journal-title":"Nature"},{"issue":"11","key":"3583_CR72","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1097\/01.jnen.0000240470.97295.d3","volume":"65","author":"JG McLarnon","year":"2006","unstructured":"McLarnon JG, Ryu JK, Walker DG, Choi HB. Upregulated expression of purinergic P2X(7) receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide-injected rat hippocampus. J Neuropathol Exp Neurol. 2006;65(11):1090\u20137. https:\/\/doi.org\/10.1097\/01.jnen.0000240470.97295.d3.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"3583_CR73","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3858\/emm.2011.43.1.001","volume":"43","author":"HG Lee","year":"2011","unstructured":"Lee HG, Won SM, Gwag BJ, Lee YB. Microglial P2X\u2087 receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease. Exp Mol Med. 2011;43(1):7\u201314. https:\/\/doi.org\/10.3858\/emm.2011.43.1.001.","journal-title":"Exp Mol Med"},{"issue":"15","key":"3583_CR74","doi-asserted-by":"publisher","first-page":"13309","DOI":"10.1074\/jbc.M209478200","volume":"278","author":"LK Parvathenani","year":"2003","unstructured":"Parvathenani LK, Tertyshnikova S, Greco CR, Roberts SB, Robertson B, Posmantur R. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer\u2019s disease. J Biol Chem. 2003;278(15):13309\u201317. https:\/\/doi.org\/10.1074\/jbc.M209478200.","journal-title":"J Biol Chem"},{"issue":"7434","key":"3583_CR75","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493(7434):674\u20138. https:\/\/doi.org\/10.1038\/nature11729.","journal-title":"Nature"},{"issue":"7784","key":"3583_CR76","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575(7784):669\u201373. https:\/\/doi.org\/10.1038\/s41586-019-1769-z.","journal-title":"Nature"},{"issue":"8","key":"3583_CR77","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/088307389701200802","volume":"12","author":"P Bittigau","year":"1997","unstructured":"Bittigau P, Ikonomidou C. Topical Review: Glutamate in Neurologic Diseases. J Child Neurol. 1997;12(8):471\u201385. https:\/\/doi.org\/10.1177\/088307389701200802.","journal-title":"J Child Neurol"},{"key":"3583_CR78","doi-asserted-by":"publisher","first-page":"136431","DOI":"10.1016\/j.neulet.2021.136431","volume":"769","author":"H Du","year":"2022","unstructured":"Du H, Tan Y, Li CH, Zhao Y, Li P, Ning YL, et al. High glutamate concentration reverses the inhibitory effect of microglial adenosine 2A receptor on NLRP3 inflammasome assembly and activation. Neurosci Lett. 2022;769:136431. https:\/\/doi.org\/10.1016\/j.neulet.2021.136431.","journal-title":"Neurosci Lett"},{"issue":"8","key":"3583_CR79","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.7150\/ijbs.34211","volume":"15","author":"W Zhao","year":"2019","unstructured":"Zhao W, Ma L, Cai C, Gong X. Caffeine Inhibits NLRP3 Inflammasome Activation by Suppressing MAPK\/NF-\u03baB and A2aR Signaling in LPS-Induced THP-1 Macrophages. Int J Biol Sci. 2019;15(8):1571\u201381. https:\/\/doi.org\/10.7150\/ijbs.34211.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"3583_CR80","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ana.21313","volume":"63","author":"L Yu","year":"2008","unstructured":"Yu L, Shen HY, Coelho JE, Ara\u00fajo IM, Huang QY, Day YJ, et al. Adenosine A2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms. Ann Neurol. 2008;63(3):338\u201346. https:\/\/doi.org\/10.1002\/ana.21313.","journal-title":"Ann Neurol"},{"issue":"3","key":"3583_CR81","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/brain\/awy351","volume":"142","author":"F Meng","year":"2019","unstructured":"Meng F, Guo Z, Hu Y, Mai W, Zhang Z, Zhang B, et al. CD73-derived adenosine controls inflammation and neurodegeneration by modulating dopamine signalling. Brain. 2019;142(3):700\u201318. https:\/\/doi.org\/10.1093\/brain\/awy351.","journal-title":"Brain"},{"issue":"3","key":"3583_CR82","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nn.3930","volume":"18","author":"AG Orr","year":"2015","unstructured":"Orr AG, Hsiao EC, Wang MM, Ho K, Kim DH, Wang X, et al. Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory. Nat Neurosci. 2015;18(3):423\u201334. https:\/\/doi.org\/10.1038\/nn.3930.","journal-title":"Nat Neurosci"},{"issue":"3","key":"3583_CR83","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3233\/jad-2012-120469","volume":"31","author":"M Matos","year":"2012","unstructured":"Matos M, Augusto E, Machado NJ, dos Santos-Rodrigues A, Cunha RA, Agostinho P. Astrocytic adenosine A2A receptors control the amyloid-\u03b2 peptide-induced decrease of glutamate uptake. J Alzheimers Dis. 2012;31(3):555\u201367. https:\/\/doi.org\/10.3233\/jad-2012-120469.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"3583_CR84","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1523\/jneurosci.23-06-02348.2003","volume":"23","author":"JT Neary","year":"2003","unstructured":"Neary JT, Kang Y, Willoughby KA, Ellis EF. Activation of extracellular signal-regulated kinase by stretch-induced injury in astrocytes involves extracellular ATP and P2 purinergic receptors. J Neurosci. 2003;23(6):2348\u201356. https:\/\/doi.org\/10.1523\/jneurosci.23-06-02348.2003.","journal-title":"J Neurosci"},{"issue":"19","key":"3583_CR85","doi-asserted-by":"publisher","first-page":"18696","DOI":"10.1074\/jbc.M500219200","volume":"280","author":"JM Camden","year":"2005","unstructured":"Camden JM, Schrader AM, Camden RE, Gonz\u00e1lez FA, Erb L, Seye CI, et al. P2Y2 nucleotide receptors enhance alpha-secretase-dependent amyloid precursor protein processing. J Biol Chem. 2005;280(19):18696\u2013702. https:\/\/doi.org\/10.1074\/jbc.M500219200.","journal-title":"J Biol Chem"},{"issue":"6","key":"3583_CR86","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/SHK.0b013e3181a20792","volume":"32","author":"T Genovese","year":"2009","unstructured":"Genovese T, Melani A, Esposito E, Mazzon E, Di Paola R, Bramanti P, et al. The selective adenosine A2A receptor agonist CGS 21680 reduces JNK MAPK activation in oligodendrocytes in injured spinal cord. Shock. 2009;32(6):578\u201385. https:\/\/doi.org\/10.1097\/SHK.0b013e3181a20792.","journal-title":"Shock"},{"issue":"1","key":"3583_CR87","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2174\/1570159x113119990045","volume":"12","author":"R D\u00fcster","year":"2014","unstructured":"D\u00fcster R, Prickaerts J, Blokland A. Purinergic signaling and hippocampal long-term potentiation. Curr Neuropharmacol. 2014;12(1):37\u201343. https:\/\/doi.org\/10.2174\/1570159x113119990045.","journal-title":"Curr Neuropharmacol"},{"issue":"6","key":"3583_CR88","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrn1928","volume":"7","author":"RD Fields","year":"2006","unstructured":"Fields RD, Burnstock G. Purinergic signalling in neuron\u2013glia interactions. Nat Rev Neurosci. 2006;7(6):423\u201336. https:\/\/doi.org\/10.1038\/nrn1928.","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"3583_CR89","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1113\/jphysiol.2014.279901","volume":"593","author":"P Zhang","year":"2015","unstructured":"Zhang P, Bannon NM, Ilin V, Volgushev M, Chistiakova M. Adenosine effects on inhibitory synaptic transmission and excitation-inhibition balance in the rat neocortex. J Physiol. 2015;593(4):825\u201341. https:\/\/doi.org\/10.1113\/jphysiol.2014.279901.","journal-title":"J Physiol"},{"issue":"12","key":"3583_CR90","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1523\/jneurosci.4454-03.2004","volume":"24","author":"MJ Di\u00f3genes","year":"2004","unstructured":"Di\u00f3genes MJ, Fernandes CC, Sebasti\u00e3o AM, Ribeiro JA. Activation of adenosine A2A receptor facilitates brain-derived neurotrophic factor modulation of synaptic transmission in hippocampal slices. J Neurosci. 2004;24(12):2905\u201313. https:\/\/doi.org\/10.1523\/jneurosci.4454-03.2004.","journal-title":"J Neurosci"},{"key":"3583_CR91","doi-asserted-by":"publisher","first-page":"1207393","DOI":"10.1155\/2016\/1207393","volume":"2016","author":"SJ Guzman","year":"2016","unstructured":"Guzman SJ, Gerevich Z. P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive Dysfunction. Neural Plast. 2016;2016:1207393. https:\/\/doi.org\/10.1155\/2016\/1207393.","journal-title":"Neural Plast"},{"issue":"1","key":"3583_CR92","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neuroscience.2008.03.076","volume":"158","author":"Y Pankratov","year":"2009","unstructured":"Pankratov Y, Lalo U, Krishtal OA, Verkhratsky A. P2X receptors and synaptic plasticity. Neuroscience. 2009;158(1):137\u201348. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.03.076.","journal-title":"Neuroscience"},{"issue":"6","key":"3583_CR93","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.neuint.2005.05.014","volume":"47","author":"A Melani","year":"2005","unstructured":"Melani A, Turchi D, Vannucchi MG, Cipriani S, Gianfriddo M, Pedata F. ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia. Neurochem Int. 2005;47(6):442\u20138. https:\/\/doi.org\/10.1016\/j.neuint.2005.05.014.","journal-title":"Neurochem Int"},{"issue":"8","key":"3583_CR94","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/nm1082","volume":"10","author":"X Wang","year":"2004","unstructured":"Wang X, Arcuino G, Takano T, Lin J, Peng WG, Wan P, et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med. 2004;10(8):821\u20137. https:\/\/doi.org\/10.1038\/nm1082.","journal-title":"Nat Med"},{"issue":"6","key":"3583_CR95","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/glia.20958","volume":"58","author":"M Domercq","year":"2010","unstructured":"Domercq M, Perez-Samartin A, Aparicio D, Alberdi E, Pampliega O, Matute C. P2X7 receptors mediate ischemic damage to oligodendrocytes. Glia. 2010;58(6):730\u201340. https:\/\/doi.org\/10.1002\/glia.20958.","journal-title":"Glia"},{"issue":"30","key":"3583_CR96","doi-asserted-by":"publisher","first-page":"12489","DOI":"10.1073\/pnas.0902531106","volume":"106","author":"W Peng","year":"2009","unstructured":"Peng W, Cotrina ML, Han X, Yu H, Bekar L, Blum L, et al. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc Natl Acad Sci U S A. 2009;106(30):12489\u201393. https:\/\/doi.org\/10.1073\/pnas.0902531106.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"3583_CR97","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1523\/jneurosci.18-13-04891.1998","volume":"18","author":"N Braun","year":"1998","unstructured":"Braun N, Zhu Y, Krieglstein J, Culmsee C, Zimmermann H. Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat. J Neurosci. 1998;18(13):4891\u2013900. https:\/\/doi.org\/10.1523\/jneurosci.18-13-04891.1998.","journal-title":"J Neurosci"},{"issue":"2","key":"3583_CR98","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/0006-8993(89)90058-9","volume":"491","author":"JL Daval","year":"1989","unstructured":"Daval JL, Von Lubitz DK, Deckert J, Redmond DJ, Marangos PJ. Protective effect of cyclohexyladenosine on adenosine A1-receptors, guanine nucleotide and forskolin binding sites following transient brain ischemia: a quantitative autoradiographic study. Brain Res. 1989;491(2):212\u201326. https:\/\/doi.org\/10.1016\/0006-8993(89)90058-9.","journal-title":"Brain Res"},{"issue":"21","key":"3583_CR99","doi-asserted-by":"publisher","first-page":"9192","DOI":"10.1523\/jneurosci.19-21-09192.1999","volume":"19","author":"JF Chen","year":"1999","unstructured":"Chen JF, Huang Z, Ma J, Zhu J, Moratalla R, Standaert D, et al. A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci. 1999;19(21):9192\u2013200. https:\/\/doi.org\/10.1523\/jneurosci.19-21-09192.1999.","journal-title":"J Neurosci"},{"issue":"2","key":"3583_CR100","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1179\/016164105x21913","volume":"27","author":"F Pedata","year":"2005","unstructured":"Pedata F, Gianfriddo M, Turchi D, Melani A. The protective effect of adenosine A2A receptor antagonism in cerebral ischemia. Neurol Res. 2005;27(2):169\u201374. https:\/\/doi.org\/10.1179\/016164105x21913.","journal-title":"Neurol Res"},{"issue":"10","key":"3583_CR101","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/nm1103","volume":"10","author":"L Yu","year":"2004","unstructured":"Yu L, Huang Z, Mariani J, Wang Y, Moskowitz M, Chen JF. Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury. Nat Med. 2004;10(10):1081\u20137. https:\/\/doi.org\/10.1038\/nm1103.","journal-title":"Nat Med"},{"issue":"12","key":"3583_CR102","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","volume":"22","author":"KE Attfield","year":"2022","unstructured":"Attfield KE, Jensen LT, Kaufmann M, Friese MA, Fugger L. The immunology of multiple sclerosis. Nat Rev Immunol. 2022;22(12):734\u201350. https:\/\/doi.org\/10.1038\/s41577-022-00718-z.","journal-title":"Nat Rev Immunol"},{"key":"3583_CR103","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2377-6-12","volume":"6","author":"Y Yiangou","year":"2006","unstructured":"Yiangou Y, Facer P, Durrenberger P, Chessell IP, Naylor A, Bountra C, et al. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol. 2006;6:12. https:\/\/doi.org\/10.1186\/1471-2377-6-12.","journal-title":"BMC Neurol"},{"issue":"2","key":"3583_CR104","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/glia.20110","volume":"49","author":"L Narcisse","year":"2005","unstructured":"Narcisse L, Scemes E, Zhao Y, Lee SC, Brosnan CF. The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes. Glia. 2005;49(2):245\u201358. https:\/\/doi.org\/10.1002\/glia.20110.","journal-title":"Glia"},{"issue":"2","key":"3583_CR105","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.brainresrev.2004.12.005","volume":"48","author":"C Agresti","year":"2005","unstructured":"Agresti C, Meomartini ME, Amadio S, Ambrosini E, Volont\u00e9 C, Aloisi F, et al. ATP regulates oligodendrocyte progenitor migration, proliferation, and differentiation: involvement of metabotropic P2 receptors. Brain Res Brain Res Rev. 2005;48(2):157\u201365. https:\/\/doi.org\/10.1016\/j.brainresrev.2004.12.005.","journal-title":"Brain Res Brain Res Rev"},{"issue":"35","key":"3583_CR106","doi-asserted-by":"publisher","first-page":"9525","DOI":"10.1523\/jneurosci.0579-07.2007","volume":"27","author":"C Matute","year":"2007","unstructured":"Matute C, Torre I, P\u00e9rez-Cerd\u00e1 F, P\u00e9rez-Samart\u00edn A, Alberdi E, Etxebarria E, et al. P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J Neurosci. 2007;27(35):9525\u201333. https:\/\/doi.org\/10.1523\/jneurosci.0579-07.2007.","journal-title":"J Neurosci"},{"issue":"3\u20134","key":"3583_CR107","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.cca.2009.11.005","volume":"411","author":"RM Spanevello","year":"2010","unstructured":"Spanevello RM, Mazzanti CM, Schmatz R, Thom\u00e9 G, Bagatini M, Correa M, et al. The activity and expression of NTPDase is altered in lymphocytes of multiple sclerosis patients. Clin Chim Acta. 2010;411(3\u20134):210\u20134. https:\/\/doi.org\/10.1016\/j.cca.2009.11.005.","journal-title":"Clin Chim Acta"},{"key":"3583_CR108","doi-asserted-by":"publisher","first-page":"998023","DOI":"10.3389\/fnmol.2022.998023","volume":"15","author":"B Kutryb-Zajac","year":"2022","unstructured":"Kutryb-Zajac B, Kawecka A, Caratis F, Urbanowicz K, Braczko A, Furihata T, et al. The impaired distribution of adenosine deaminase isoenzymes in multiple sclerosis plasma and cerebrospinal fluid. Front Mol Neurosci. 2022;15:998023. https:\/\/doi.org\/10.3389\/fnmol.2022.998023.","journal-title":"Front Mol Neurosci"},{"issue":"8","key":"3583_CR109","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1002\/eji.201343314","volume":"43","author":"F Vincenzi","year":"2013","unstructured":"Vincenzi F, Corciulo C, Targa M, Merighi S, Gessi S, Casetta I, et al. Multiple sclerosis lymphocytes upregulate A2A adenosine receptors that are antiinflammatory when stimulated. Eur J Immunol. 2013;43(8):2206\u201316. https:\/\/doi.org\/10.1002\/eji.201343314.","journal-title":"Eur J Immunol"},{"issue":"9","key":"3583_CR110","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/jcbfm.2013.85","volume":"33","author":"E Rissanen","year":"2013","unstructured":"Rissanen E, Virta JR, Paavilainen T, Tuisku J, Helin S, Luoto P, et al. Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study. J Cereb Blood Flow Metab. 2013;33(9):1394\u2013401. https:\/\/doi.org\/10.1038\/jcbfm.2013.85.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9996","key":"3583_CR111","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/s0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386(9996):896\u2013912. https:\/\/doi.org\/10.1016\/s0140-6736(14)61393-3.","journal-title":"Lancet"},{"issue":"6","key":"3583_CR112","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00702-010-0400-0","volume":"117","author":"D Marcellino","year":"2010","unstructured":"Marcellino D, Su\u00e1rez-Boomgaard D, S\u00e1nchez-Reina MD, Aguirre JA, Yoshitake T, Yoshitake S, et al. On the role of P2X(7) receptors in dopamine nerve cell degeneration in a rat model of Parkinson\u2019s disease: studies with the P2X(7) receptor antagonist A-438079. J Neural Transm (Vienna). 2010;117(6):681\u20137. https:\/\/doi.org\/10.1007\/s00702-010-0400-0.","journal-title":"J Neural Transm (Vienna)"},{"key":"3583_CR113","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1750-1326-6-28","volume":"6","author":"Z Hracsk\u00f3","year":"2011","unstructured":"Hracsk\u00f3 Z, Baranyi M, Cs\u00f6lle C, G\u00f6l\u00f6ncs\u00e9r F, Madar\u00e1sz E, Kittel A, et al. Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson\u2019s disease. Mol Neurodegener. 2011;6:28. https:\/\/doi.org\/10.1186\/1750-1326-6-28.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"3583_CR114","doi-asserted-by":"publisher","first-page":"712","DOI":"10.4103\/1673-5374.266916","volume":"15","author":"YC Lv","year":"2020","unstructured":"Lv YC, Gao AB, Yang J, Zhong LY, Jia B, Ouyang SH, et al. Long-term adenosine A1 receptor activation-induced sortilin expression promotes \u03b1-synuclein upregulation in dopaminergic neurons. Neural Regen Res. 2020;15(4):712\u201323. https:\/\/doi.org\/10.4103\/1673-5374.266916.","journal-title":"Neural Regen Res"},{"issue":"1","key":"3583_CR115","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40035-022-00284-3","volume":"11","author":"E Jakova","year":"2022","unstructured":"Jakova E, Moutaoufik MT, Lee JS, Babu M, Cayabyab FS. Adenosine A1 receptor ligands bind to \u03b1-synuclein: implications for \u03b1-synuclein misfolding and \u03b1-synucleinopathy in Parkinson\u2019s disease. Translational Neurodegeneration. 2022;11(1):9. https:\/\/doi.org\/10.1186\/s40035-022-00284-3.","journal-title":"Translational Neurodegeneration"},{"issue":"10","key":"3583_CR116","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/s0166-2236(97)01096-5","volume":"20","author":"S Ferr\u00e9","year":"1997","unstructured":"Ferr\u00e9 S, Fredholm BB, Morelli M, Popoli P, Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 1997;20(10):482\u20137. https:\/\/doi.org\/10.1016\/s0166-2236(97)01096-5.","journal-title":"Trends Neurosci"},{"issue":"1\u20132","key":"3583_CR117","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.physbeh.2007.05.034","volume":"92","author":"K Fuxe","year":"2007","unstructured":"Fuxe K, Ferr\u00e9 S, Genedani S, Franco R, Agnati LF. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol Behav. 2007;92(1\u20132):210\u20137. https:\/\/doi.org\/10.1016\/j.physbeh.2007.05.034.","journal-title":"Physiol Behav"},{"issue":"3","key":"3583_CR118","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s12035-022-03162-1","volume":"60","author":"FQ Gon\u00e7alves","year":"2023","unstructured":"Gon\u00e7alves FQ, Matheus FC, Silva HB, Real JI, Rial D, Rodrigues RJ, et al. Increased ATP Release and Higher Impact of Adenosine A2A Receptors on Corticostriatal Plasticity in a Rat Model of Presymptomatic Parkinson\u2019s Disease. Mol Neurobiol. 2023;60(3):1659\u201374. https:\/\/doi.org\/10.1007\/s12035-022-03162-1.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"3583_CR119","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.neuropharm.2009.11.012","volume":"58","author":"A Pinna","year":"2010","unstructured":"Pinna A, Tronci E, Schintu N, Simola N, Volpini R, Pontis S, et al. A new ethyladenine antagonist of adenosine A2A receptors: Behavioral and biochemical characterization as an antiparkinsonian drug. Neuropharmacology. 2010;58(3):613\u201323. https:\/\/doi.org\/10.1016\/j.neuropharm.2009.11.012.","journal-title":"Neuropharmacology"},{"issue":"2","key":"3583_CR120","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1006\/exnr.2000.7350","volume":"162","author":"T Kanda","year":"2000","unstructured":"Kanda T, Jackson MJ, Smith LA, Pearce RK, Nakamura J, Kase H, et al. Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys. Exp Neurol. 2000;162(2):321\u20137. https:\/\/doi.org\/10.1006\/exnr.2000.7350.","journal-title":"Exp Neurol"},{"issue":"8","key":"3583_CR121","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1212\/wnl.52.8.1673","volume":"52","author":"R Grondin","year":"1999","unstructured":"Grondin R, B\u00e9dard PJ, Hadj Tahar A, Gr\u00e9goire L, Mori A, Kase H. Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys. Neurology. 1999;52(8):1673\u20137. https:\/\/doi.org\/10.1212\/wnl.52.8.1673.","journal-title":"Neurology"},{"issue":"1","key":"3583_CR122","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bj.2018.01.003","volume":"41","author":"C Laurent","year":"2018","unstructured":"Laurent C, Bu\u00e9e L, Blum D. Tau and neuroinflammation: What impact for Alzheimer\u2019s Disease and Tauopathies? Biomedical J. 2018;41(1):21\u201333. https:\/\/doi.org\/10.1016\/j.bj.2018.01.003.","journal-title":"Biomedical J"},{"issue":"2","key":"3583_CR123","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1586\/14789450.5.2.207","volume":"5","author":"N Sergeant","year":"2008","unstructured":"Sergeant N, Bretteville A, Hamdane M, Caillet-Boudin ML, Grognet P, Bombois S, et al. Biochemistry of Tau in Alzheimer\u2019s disease and related neurological disorders. Expert Rev Proteom. 2008;5(2):207\u201324. https:\/\/doi.org\/10.1586\/14789450.5.2.207.","journal-title":"Expert Rev Proteom"},{"key":"3583_CR124","doi-asserted-by":"publisher","first-page":"109379","DOI":"10.1016\/j.neuropharm.2022.109379","volume":"226","author":"A Launay","year":"2023","unstructured":"Launay A, Nebie O, Vijaya Shankara J, Lebouvier T, Bu\u00e9e L, Faivre E, et al. The role of adenosine A2A receptors in Alzheimer\u2019s disease and tauopathies. Neuropharmacology. 2023;226:109379. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109379.","journal-title":"Neuropharmacology"},{"issue":"47","key":"3583_CR125","doi-asserted-by":"publisher","first-page":"14741","DOI":"10.1523\/jneurosci.3728-09.2009","volume":"29","author":"PM Canas","year":"2009","unstructured":"Canas PM, Porci\u00fancula LO, Cunha GM, Silva CG, Machado NJ, Oliveira JM, et al. Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway. J Neurosci. 2009;29(47):14741\u201351. https:\/\/doi.org\/10.1523\/jneurosci.3728-09.2009.","journal-title":"J Neurosci"},{"key":"3583_CR126","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fnmol.2018.00235","volume":"11","author":"E Faivre","year":"2018","unstructured":"Faivre E, Coelho JE, Zornbach K, Malik E, Baqi Y, Schneider M, et al. Beneficial Effect of a Selective Adenosine A(2A) Receptor Antagonist in the APPswe\/PS1dE9 Mouse Model of Alzheimer\u2019s Disease. Front Mol Neurosci. 2018;11:235. https:\/\/doi.org\/10.3389\/fnmol.2018.00235.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"3583_CR127","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/mp.2014.151","volume":"21","author":"C Laurent","year":"2016","unstructured":"Laurent C, Burnouf S, Ferry B, Batalha VL, Coelho JE, Baqi Y, et al. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy. Mol Psychiatry. 2016;21(1):97\u2013107. https:\/\/doi.org\/10.1038\/mp.2014.151.","journal-title":"Mol Psychiatry"},{"issue":"7","key":"3583_CR128","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.4049\/jimmunol.0803612","volume":"182","author":"JM Sanz","year":"2009","unstructured":"Sanz JM, Chiozzi P, Ferrari D, Colaianna M, Idzko M, Falzoni S, et al. Activation of Microglia by Amyloid \u03b2 Requires P2X7 Receptor Expression1. J Immunol. 2009;182(7):4378\u201385. https:\/\/doi.org\/10.4049\/jimmunol.0803612.","journal-title":"J Immunol"},{"issue":"4","key":"3583_CR129","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1074\/jbc.M110.200618","volume":"286","author":"C Delarasse","year":"2011","unstructured":"Delarasse C, Auger R, Gonnord P, Fontaine B, Kanellopoulos JM. The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein. J Biol Chem. 2011;286(4):2596\u2013606. https:\/\/doi.org\/10.1074\/jbc.M110.200618.","journal-title":"J Biol Chem"},{"issue":"2","key":"3583_CR130","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12017-009-8073-2","volume":"11","author":"R Varma","year":"2009","unstructured":"Varma R, Chai Y, Troncoso J, Gu J, Xing H, Stojilkovic SS, et al. Amyloid-beta induces a caspase-mediated cleavage of P2X4 to promote purinotoxicity. Neuromolecular Med. 2009;11(2):63\u201375. https:\/\/doi.org\/10.1007\/s12017-009-8073-2.","journal-title":"Neuromolecular Med"},{"issue":"3","key":"3583_CR131","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0306-4522(90)90246-z","volume":"39","author":"KL Jansen","year":"1990","unstructured":"Jansen KL, Faull RL, Dragunow M, Synek BL. Alzheimer\u2019s disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors\u2013an autoradiographic study. Neuroscience. 1990;39(3):613\u201327. https:\/\/doi.org\/10.1016\/0306-4522(90)90246-z.","journal-title":"Neuroscience"},{"issue":"2","key":"3583_CR132","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1750-3639.2007.00112.x","volume":"18","author":"JL Albasanz","year":"2008","unstructured":"Albasanz JL, Perez S, Barrachina M, Ferrer I, Mart\u00edn M. Up-regulation of adenosine receptors in the frontal cortex in Alzheimer\u2019s disease. Brain Pathol. 2008;18(2):211\u20139. https:\/\/doi.org\/10.1111\/j.1750-3639.2007.00112.x.","journal-title":"Brain Pathol"},{"issue":"4","key":"3583_CR133","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1750-3639.2003.tb00475.x","volume":"13","author":"E Angulo","year":"2003","unstructured":"Angulo E, Casad\u00f3 V, Mallol J, Canela EI, Vi\u00f1als F, Ferrer I, et al. A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation. Brain Pathol. 2003;13(4):440\u201351. https:\/\/doi.org\/10.1111\/j.1750-3639.2003.tb00475.x.","journal-title":"Brain Pathol"},{"key":"3583_CR134","doi-asserted-by":"publisher","first-page":"31493","DOI":"10.1038\/srep31493","volume":"6","author":"VL Batalha","year":"2016","unstructured":"Batalha VL, Ferreira DG, Coelho JE, Valadas JS, Gomes R, Temido-Ferreira M, et al. The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. Sci Rep. 2016;6:31493. https:\/\/doi.org\/10.1038\/srep31493.","journal-title":"Sci Rep"},{"issue":"8","key":"3583_CR135","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1038\/s41380-018-0110-9","volume":"25","author":"M Temido-Ferreira","year":"2020","unstructured":"Temido-Ferreira M, Ferreira DG, Batalha VL, Marques-Morgado I, Coelho JE, Pereira P, et al. Age-related shift in LTD is dependent on neuronal adenosine A(2A) receptors interplay with mGluR5 and NMDA receptors. Mol Psychiatry. 2020;25(8):1876\u2013900. https:\/\/doi.org\/10.1038\/s41380-018-0110-9.","journal-title":"Mol Psychiatry"},{"issue":"11","key":"3583_CR136","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1093\/brain\/awz288","volume":"142","author":"K Carvalho","year":"2019","unstructured":"Carvalho K, Faivre E, Pietrowski MJ, Marques X, Gomez-Murcia V, Deleau A, et al. Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor. Brain. 2019;142(11):3636\u201354. https:\/\/doi.org\/10.1093\/brain\/awz288.","journal-title":"Brain"},{"issue":"8","key":"3583_CR137","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s40265-013-0066-7","volume":"73","author":"R Dungo","year":"2013","unstructured":"Dungo R, Deeks ED. Istradefylline: first global approval. Drugs. 2013;73(8):875\u201382. https:\/\/doi.org\/10.1007\/s40265-013-0066-7.","journal-title":"Drugs"},{"issue":"8","key":"3583_CR138","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/mds.28095","volume":"35","author":"N Hattori","year":"2020","unstructured":"Hattori N, Kitabayashi H, Kanda T, Nomura T, Toyama K, Mori A. A Pooled Analysis From Phase 2b and 3 Studies in Japan of Istradefylline in Parkinson\u2019s Disease. Mov Disord. 2020;35(8):1481\u20137. https:\/\/doi.org\/10.1002\/mds.28095.","journal-title":"Mov Disord"},{"key":"3583_CR139","doi-asserted-by":"publisher","first-page":"109379","DOI":"10.1016\/j.neuropharm.2022.109379","volume":"226","author":"A Launay","year":"2023","unstructured":"Launay A, Nebie O, Vijaya Shankara J, Lebouvier T, Bu\u00e9e L, Faivre E, et al. The role of adenosine A(2A) receptors in Alzheimer\u2019s disease and tauopathies. Neuropharmacology. 2023;226:109379. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109379.","journal-title":"Neuropharmacology"},{"issue":"37","key":"3583_CR140","doi-asserted-by":"publisher","first-page":"13272","DOI":"10.1523\/jneurosci.3337-11.2011","volume":"31","author":"AJ Carman","year":"2011","unstructured":"Carman AJ, Mills JH, Krenz A, Kim DG, Bynoe MS. Adenosine receptor signaling modulates permeability of the blood-brain barrier. J Neurosci. 2011;31(37):13272\u201380. https:\/\/doi.org\/10.1523\/jneurosci.3337-11.2011.","journal-title":"J Neurosci"},{"issue":"1","key":"3583_CR141","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s12035-014-8879-2","volume":"52","author":"DG Kim","year":"2015","unstructured":"Kim DG, Bynoe MS. A2A Adenosine Receptor Regulates the Human Blood-Brain Barrier Permeability. Mol Neurobiol. 2015;52(1):664\u201378. https:\/\/doi.org\/10.1007\/s12035-014-8879-2.","journal-title":"Mol Neurobiol"},{"key":"3583_CR142","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fchem.2018.00248","volume":"6","author":"CNJ Young","year":"2018","unstructured":"Young CNJ, G\u00f3recki DC. P2RX7 Purinoceptor as a Therapeutic Target-The Second Coming? Front Chem. 2018;6:248. https:\/\/doi.org\/10.3389\/fchem.2018.00248.","journal-title":"Front Chem"},{"key":"3583_CR143","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1742-2094-5-33","volume":"5","author":"AJ Sharp","year":"2008","unstructured":"Sharp AJ, Polak PE, Simonini V, Lin SX, Richardson JC, Bongarzone ER, et al. P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis. J Neuroinflammation. 2008;5:33. https:\/\/doi.org\/10.1186\/1742-2094-5-33.","journal-title":"J Neuroinflammation"},{"issue":"366","key":"3583_CR144","doi-asserted-by":"publisher","first-page":"366ra162","DOI":"10.1126\/scitranslmed.aaf8463","volume":"8","author":"W Danquah","year":"2016","unstructured":"Danquah W, Meyer-Schwesinger C, Rissiek B, Pinto C, Serracant-Prat A, Amadi M, et al. Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation. Sci Transl Med. 2016;8(366):366ra162. https:\/\/doi.org\/10.1126\/scitranslmed.aaf8463.","journal-title":"Sci Transl Med"},{"key":"3583_CR145","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.coph.2019.03.001","volume":"47","author":"F Koch-Nolte","year":"2019","unstructured":"Koch-Nolte F, Eichhoff A, Pinto-Espinoza C, Schwarz N, Sch\u00e4fer T, Menzel S, et al. Novel biologics targeting the P2X7 ion channel. Curr Opin Pharmacol. 2019;47:110\u20138. https:\/\/doi.org\/10.1016\/j.coph.2019.03.001.","journal-title":"Curr Opin Pharmacol"},{"issue":"4","key":"3583_CR146","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11302-007-9069-8","volume":"3","author":"S Amadio","year":"2007","unstructured":"Amadio S, Montilli C, Picconi B, Calabresi P, Volont\u00e9 C. Mapping P2X and P2Y receptor proteins in striatum and substantia nigra: An immunohistological study. Purinergic Signalling. 2007;3(4):389\u201398. https:\/\/doi.org\/10.1007\/s11302-007-9069-8.","journal-title":"Purinergic Signalling"},{"issue":"6","key":"3583_CR147","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1523\/jneurosci.4271-03.2004","volume":"24","author":"S Tsutsui","year":"2004","unstructured":"Tsutsui S, Schnermann J, Noorbakhsh F, Henry S, Yong VW, Winston BW, et al. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J Neurosci. 2004;24(6):1521\u20139. https:\/\/doi.org\/10.1523\/jneurosci.4271-03.2004.","journal-title":"J Neurosci"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03583-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-026-03583-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03583-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:41:52Z","timestamp":1792039312000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-026-03583-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":147,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3583"],"URL":"https:\/\/doi.org\/10.1007\/s00044-026-03583-w","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"15 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}